About Oncotherapeutics
Oncotherapeutics is a company based in West Hollywood (United States) founded in 1988. Oncotherapeutics has raised $8.3 million across 1 funding round from investors including Domain Associates and TVM Capital Life Science. Oncotherapeutics operates in a competitive market with competitors including Helsinn, Aster Insights, CancerVax, Abogen Biosciences and OnCusp, among others.
- Headquarter West Hollywood, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.3 M (USD)
in 1 rounds
-
Latest Funding Round
$8.3 M (USD), Series A
Jun 01, 1993
-
Investors
Domain Associates
& 2 more
-
Employee Count
Not available
-
Acquired by
N/A
(Sep 04, 1995)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oncotherapeutics
Oncotherapeutics has successfully raised a total of $8.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.3 million completed in June 1993. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oncotherapeutics
Oncotherapeutics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Domain Associates and TVM Capital Life Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science & tech focused VC firm investing in the US
|
Locked | Locked | Locked | |
|
Capital is invested in life science innovations for healthcare transformation.
|
Locked | Locked | Locked |
Investor details for Oncotherapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oncotherapeutics
Investment portfolio details for Oncotherapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oncotherapeutics
Detailed financials for Oncotherapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oncotherapeutics Comparisons
Peer comparison for Oncotherapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oncotherapeutics
Oncotherapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, CancerVax, Abogen Biosciences and OnCusp, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
|
| Locked | Locked | Locked |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| Locked | Locked | Locked |
Cancer vaccine research and development is conducted by CancerVax.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| Locked | Locked | Locked |
CRO offering clinical development services for oncology drugs
|
Detailed competitors of Oncotherapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oncotherapeutics
Complete news archive for Oncotherapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncotherapeutics
Oncotherapeutics was founded in 1988 and raised its 1st funding round 5 years after it was founded.
Oncotherapeutics is headquartered in West Hollywood, United States. It is registered at West Hollywood, California, United States.
James Berenson is the current CEO of Oncotherapeutics.
Oncotherapeutics is a funded company, having raised a total of $8.3M across 1 funding round to date.
Oncotherapeutics was founded in 1988 and is based in West Hollywood, United States. As a contract research organization in the oncology sector, services are extended for drug development across preclinical and phase I-IV clinical trials. Offerings encompass project team management, medical writing, data management and analysis, regulatory submissions, CRFeCRF design, patient recruitment, and protocol development. Operations emphasize timelines for study start-up, enrollment, and completion.
Oncotherapeutics has 2 investors. Key investors include Domain Associates, and TVM Capital Life Science.